1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Cerebral Therapeutics, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2010

Location

Aurora CO US

Primary Industry

Biotechnology

About

Founded in 2010 and based in Colorado, US, Cerebral Therapeutics, LLC. is a pharmaceutical company focused on developing implanted devices for the treatment of refractory epilepsy and neurological diseases. It offers CT001, a specialized implanted, refillable catheter and pump system that delivers a continuous intracerebroventricular (ICV) dose of a proprietary formulation of the anti-epileptic drug valproic acid.
Current Investors
Vivo Capital, Granite Point Capital Management, RA Capital Management

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Biomaterials
Website
www.cerebraltherapeutics.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo